TVGN Stock Summary and Trading Ideas (Tevogen Bio Holdings | NASDAQ:TVGN)

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings trades on the NASDAQ stock market under the symbol TVGN.

As of March 27, 2026, TVGN stock price declined to $4.36 with 38,699 million shares trading.

TVGN has a beta of 1.47, meaning it tends to be more sensitive to market movements. TVGN has a correlation of 0.08 to the broad based SPY ETF.

TVGN has a market cap of $17.67 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that TVGN belongs to (by Net Assets): VTI, VTWO, IWM, VXF, IWO.

TVGN has underperformed the market in the last year with a price return of -92.5% while the SPY ETF gained +12.8%. TVGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -77.1% and -31.6%, respectively, while the SPY returned -7.9% and -4.5%, respectively.

TVGN support price is $4.26 and resistance is $5.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVGN shares will trade within this expected range on the day.